Chemoinformaics analysis of 2-Allyl-4,5-dimethoxyphenol
| Molecular Weight | 194.23 | nRot | 4 |
| Heavy Atom Molecular Weight | 180.118 | nRig | 7 |
| Exact Molecular Weight | 194.094 | nRing | 1 |
| Solubility: LogS | -2.148 | nHRing | 0 |
| Solubility: LogP | 2.204 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 30.1111 |
| nHD | 1 | BPOL | 17.5169 |
| QED | 0.746 |
| Synth | 2.06 |
| Natural Product Likeliness | 1.019 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.458 |
| MDCK | 0.000021 |
| BBB | 0.239 |
| PPB | 0.90525 |
| VDSS | 0.925 |
| FU | 0.0522018 |
| CYP1A2-inh | 0.911 |
| CYP1A2-sub | 0.95 |
| CYP2c19-inh | 0.339 |
| CYP2c19-sub | 0.827 |
| CYP2c9-inh | 0.095 |
| CYP2c9-sub | 0.842 |
| CYP2d6-inh | 0.455 |
| CYP2d6-sub | 0.924 |
| CYP3a4-inh | 0.124 |
| CYP3a4-sub | 0.397 |
| CL | 12.844 |
| T12 | 0.881 |
| hERG | 0.012 |
| Ames | 0.058 |
| ROA | 0.095 |
| SkinSen | 0.77 |
| Carcinogencity | 0.667 |
| EI | 0.93 |
| Respiratory | 0.637 |
| NR-Aromatase | 0.093 |
| Antiviral | No |
| Prediction | 0.705635 |